Teva Announces Launch of $1,500,000,000 Offering of Senior Notes
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…
Pharmaceuticals, Biotechnology and Life Sciences
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…
Expanded Pipeline and Clinical Data Milestones Propel Company to Top Spot BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. has been named Company of…
DUBLIN–(BUSINESS WIRE)–The “US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)” report has been…
Small-volume presentation now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the availability in…
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive…
Statistically and clinically significant effects on pruritus, xanthomas and growth maintained for up to four years of treatment in Alagille…
– exoIL-12 demonstrates tumor-retained and dose-dependent pharmacology with superior anti-tumor efficacy compared to soluble recombinant IL-12 – – exoSTING shows…
LEXINGTON, Mass.–(BUSINESS WIRE)–#LiverMtg19–Fractyl Laboratories Inc. (Fractyl) today announced positive results from the Revita-2 trial evaluating Revita DMR (duodenal mucosal resurfacing)…
— AI-Based Tools for Liver Histology Assessment Contribute to Gilead’s Broader Efforts to Improve Understanding of NASH — — Data…
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…